Point-of-Care Testing
News on technologies and applications for point-of-care testing.
Abbott Gets FDA Emergency Use Authorization for Point-of-Care COVID-19 Test
The molecular test runs on the company's ID Now system, which uses isothermal nucleic acid amplification for the qualitative detection of infectious diseases.
Lucira Health Hits $90.5M in Q1 Revenues on Back of COVID-19 Test Sales
The firm also submitted its combination COVID-19 and influenza test to the US Food and Drug Administration for Emergency Use Authorization.
Cepheid Adds New Gene Target to SARS-CoV-2 Molecular Test to Account for Variants
The new version of the company's Xpert Xpress CoV-2 test received Emergency Use Authorization from the FDA.
LumiraDx Q1 Revenues up 18 Percent
The British firm said it placed about 4,000 of its point-of-care diagnostic platforms during the quarter, bringing the total installed base to 25,000.
Cue Health Q1 Revenues Rise 178 Percent on Product Sales
The company said it has shipped more than 235,000 Cue Readers through the end of Q1, including more than 72,000 readers in Q1.